4/30, 8:03 AM (Source: TeleTrader)
more TeleTrader news

AstraZeneca's Q1 revenue up 15% to $7.32 billion

AstraZeneca PLC announced its first-quarter earnings results on Friday, saying that the company's revenue annually soared 15% to reach $7.32 billion, including $275 million made in sales of its COVID-19 vaccine. AstraZeneca's reported earnings per share doubled to $1.19.

"This performance ensured another quarter of strong revenue and earnings progression, continued profitability, and cash-flow generation, despite the pandemic's ongoing negative impact on the diagnosis and treatment of many conditions. We expect the impact of COVID to reduce and anticipate a performance acceleration in the second half of 2021," CEO Pascal Soriot noted.

Given the results, AstraZeneca confirmed its guidance for full-year earnings in 2021.

Breaking the News / ND